NCT00185341View on ClinicalTrials.gov

Study to Investigate the Efficacy of a Non-hormonal Drug Against Endometriosis Associated Pelvic Pain

PHASE2CompletedINTERVENTIONAL
Enrollment

110

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Endometriosis
Interventions
DRUG

CCR1-Antagonist (BAY86-5047, ZK811752)

Given orally in a dose of 600 mg three times daily over 12 weeks

DRUG

Placebo

Placebo

Trial Locations (32)

2600

Glostrup Municipality

8200

Aarhus

12851

Prague

14700

Prague

15006

Prague

20100

Turku

22185

Lund

28040

Madrid

28046

Madrid

33000

Bordeaux

33006

Oviedo

41014

Seville

41685

Gothenburg

46010

Valencia

50036

Hradec Králové

63000

Clermont-Ferrand

69003

Lyon

70110

Kuopio

75185

Uppsala

80210

Joensuu

90100

Oulu

00029

Helsinki

00100

Helsinki

1061 AE

Amsterdam

1081 HV

Amsterdam

6229 HX

Maastricht

6525 GA

Nijmegen

08036

Barcelona

08022

Barcelona

182 88

Stockholm

541 85

Skövde

141 86

Stockholm

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY

NCT00185341 - Study to Investigate the Efficacy of a Non-hormonal Drug Against Endometriosis Associated Pelvic Pain | Biotech Hunter | Biotech Hunter